🇸🇬 Ioflupane I 123 in Singapore

Ioflupane I 123 (IOFLUPANE) regulatory status in Singapore.

Marketing authorisations

HSA

  • Status: likely_approved

HSA

  • Status: likely_approved

HSA

  • Status: likely_approved

Ioflupane I 123 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Singapore

Frequently asked questions

Is Ioflupane I 123 approved in Singapore?

Yes. HSA has authorised it; HSA has authorised it; HSA has authorised it.

Who is the marketing authorisation holder for Ioflupane I 123 in Singapore?

Ge Hlthcare Inc is the originator. The local marketing authorisation holder may differ — check the official source linked above.